S-1S-1
Jun 24, 2026Filed0001104659-26-076958
All companies
Trade Liminatus Pharma Inc
LI
Liminatus Pharma Inc
LIMNPublicArchived
Public / ArchivedUnited States(Nasdaq)Best valuation $7.86M1 market
Public listing
Listed· Nasdaq· Listing market: United StatesListing date
Not available
Offer price
Not available
Shares offered
Not available
Offering proceeds
Not available
Sources: sec-harvest, nasdaq
IPO Calendar · NasdaqIPO
LIMNPrice
$0.1170
24h
+13.59%
Valuation
$7.86M
24h volume
$767.21K
Type
IPO
Trade Liminatus Pharma IncNow trading publicly. Buy via a broker — opens in a new tab.
IPO Calendar · updated 30m ago
Financials
UnprofitableFrom SEC filings, latest FY ending Dec 31, 2025 · CIK 0001971387.
Revenue
—
Net income
-$10.21M
Gross margin
—
Cash
—
| Metric | 2025 | 2024 | 2023 |
|---|---|---|---|
| Operating income | -$2.97M | -$3.33M | — |
| Net income | -$10.21M | -$3.55M | — |
| R&D expense | — | $2.69M | — |
| Total assets | $512.8K | $5.41M | — |
| Total liabilities | $10.33M | $24.75M | — |
| Shareholders' equity | -$9.81M | -$19.34M | -$15.79M |
SEC IPO filings
FiledEDGAR filings resolved from LIMN / CIK 0001971387.
424B3424B3
Jun 3, 2026Final prospectus0001104659-26-069843
424B4424B4
Feb 18, 2026Final prospectus0001104659-26-016706
Feb 13, 2026Effective9999999995-26-000587
CORRESPfilename1.htm
Feb 11, 2026SEC correspondence0001104659-26-013338
CORRESPfilename1.htm
Feb 11, 2026SEC correspondence0001104659-26-013331
S-1S-1
Feb 11, 2026Filed0001104659-26-012942
UPLOADfilename1.pdf
Jan 6, 2026SEC correspondence0000000000-26-000092
Dec 31, 2025Confidential draft0001104659-25-125670
424B3424B3
Aug 13, 2025Final prospectus0001410578-25-001746
Aug 12, 2025Effective9999999995-25-002576
CORRESPfilename1.htm
Aug 11, 2025SEC correspondence0001104659-25-076067
Liminatus Pharma Inc IPO — frequently asked questions
- When did Liminatus Pharma Inc go public?
- Liminatus Pharma Inc has already gone public and now trades publicly on Nasdaq under the ticker LIMN.
- Can I buy Liminatus Pharma Inc stock?
- Yes — Liminatus Pharma Inc is publicly traded on Nasdaq as LIMN. You can follow its live price, valuation and post-IPO performance above.
- What is Liminatus Pharma Inc's valuation?
- Liminatus Pharma Inc's most recent valuation tracked here is $7.86M, derived from live market prices.